| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
Gene Therapy and Therapeutics Branch, National Institute of Dental and Craniofacial Research (Y.M., C.M.G., X.H., R.B.W., B.J.B.), Bethesda, Maryland 20892; National Hormone and Pituitary Program, Harbor-UCLA Medical Center (A.F.P.), Torrance, California 90509; Craniofacial and Skeletal Diseases Branch, National Institute of Dental and Craniofacial Research (K.S., P.G.R.); Animal Care Unit, National Institute of Dental and Craniofacial Research (M.F.K.); and Developmental Endocrinology Branch, National Institute of Child Health and Human Development (L.K.N.), Bethesda, Maryland 20892
Address all correspondence and requests for reprints to: Dr. Bruce J. Baum, Gene Therapy and Therapeutics Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, 10 Center Drive, MSC-1190, Building 10, Room 1N-113, Bethesda, Maryland 20892. E-mail: bruce_j_baum{at}nih.gov
We have constructed a recombinant, replication-deficient, first-generation adenovirus-encoding mouse GH (mGH), AdCMVmGH. This virus directed mGH production from an epithelial cell line in vitro in a dose-dependent manner. When injected into the quadriceps muscle or submandibular ducts of mGH-deficient Snell dwarf mice, AdCMVmGH resulted in the production of significantly elevated serum mGH levels. Furthermore, after im injection, dwarf mice increased in weight by 8% over 4 days and close to 100% by 30 days. When AdCMVmGH was administered to 3- to 4-week-old rats by iv injection to assess general metabolic responses, serum mGH, insulin-like growth factor 1, triglycerides and cholesterol levels were significantly elevated. AdCMVmGH should be a valuable experimental tool for the controlled, directed expression of mGH in preclinical mouse model studies.
This article has been cited by other articles:
![]() |
A. Sagazio, X. Xiao, Z. Wang, M. Martari, and R. Salvatori A single injection of double-stranded adeno-associated viral vector expressing GH normalizes growth in GH-deficient mice J. Endocrinol., January 1, 2008; 196(1): 79 - 88. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Stauber, H. Brown-Borg, J. Liu, M. P. Waalkes, A. Laughter, R. A. Staben, J. C. Coley, C. Swanson, K. A. Voss, J. J. Kopchick, et al. Constitutive Expression of Peroxisome Proliferator-Activated Receptor {alpha}-Regulated Genes in Dwarf Mice Mol. Pharmacol., March 1, 2005; 67(3): 681 - 694. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. B. Kaiser Editorial: Pituitary Gene Therapy--Hypotheses on the Hypophysis Endocrinology, February 1, 2001; 142(2): 528 - 531. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |